Repligen | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.49B 19M 2025-04
Align Technology USD 873.01M 170.88M 2025-03
Bio Techne USD 162.19M 21.52M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Bruker USD 92M 92.2M 2025-06
Charles River Laboratories USD 182.82M 46.53M 2025-06
Danaher USD 2.96B 964M 2025-06
Dentsply International USD 359M 39M 2025-06
Exact Sciences USD 657.1M 650.98M 2025-06
General Electric Aerospace USD 10.86B 1.54B 2025-06
Henry Schein USD 145M 18M 2025-06
Illumina USD 934M 179M 2025-06
IQVIA Holdings USD 2.04B 299M 2025-06
Mettler Toledo International USD 61.82M 2.47M 2025-06
Myriad Genetics USD 91.8M 10.6M 2025-03
Pfizer USD 1.64B 208M 2025-06
Repligen USD 708.86M 11.63M 2025-06
Revvity USD 991.85M 145.77M 2025-06
Standard Biotools USD 166.73M 43.92M 2024-12
Thermo Fisher Scientific USD 4.58B 442M 2025-06
Waters USD 367.22M 15.66M 2025-06
West Pharmaceutical Services USD 509.7M 105.5M 2025-06


Repligen Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.